Fecal microbiota transplantation combined with sintilimab and SOX as first-line treatment for advanced gastric cancer (FMT-JSNO-01): A prospective, multicenter, double-blind, randomized placebo-controlled phase II trial.

Authors: Wenyu Zhu, Ya Xue, Qiong Wang, Xuefeng Zhou, Ling Zhang, Qing Guo, Chunbin Wang, Xiaoqin Li, Hua Jiang

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2702

Source: Full article

TPS2702